BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 14656003)

  • 21. [Amylin under examination. Fibrillogenic polypeptide of pancreatic amyloid].
    Marszałek M
    Postepy Hig Med Dosw (Online); 2015 Jan; 69():14-24. PubMed ID: 25589710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetes mellitus in pancreatic cancer: is it a causal relationship?
    Katsumichi I; Pour PM
    Am J Surg; 2007 Oct; 194(4 Suppl):S71-5. PubMed ID: 17903450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biological action of pancreatic amylin: relationship with glucose metabolism, diabetes, obesity and calcium metabolism.
    Koopmans SJ; Radder JK; Krans HM; Barge RM
    Neth J Med; 1992 Aug; 41(1-2):82-90. PubMed ID: 1407245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistologic study of thyroidal medullary carcinoma and pancreatic insulinoma.
    Arnal-Monreal FM; Goltzman D; Knaack J; Wang NS; Huang SN
    Cancer; 1977 Sep; 40(3):1060-70. PubMed ID: 198085
    [No Abstract]   [Full Text] [Related]  

  • 25. Pancreatic cancer cells selectively stimulate islet beta cells to secrete amylin.
    Ding X; Flatt PR; Permert J; Adrian TE
    Gastroenterology; 1998 Jan; 114(1):130-8. PubMed ID: 9428227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma.
    Bishop JA; Sharma R; Illei PB
    Hum Pathol; 2010 Jan; 41(1):20-5. PubMed ID: 19740516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of augmentation of tumor spectrum or severity in dual heterozygous Men1 and Rb1 knockout mice.
    Loffler KA; Biondi CA; Gartside MG; Serewko-Auret MM; Duncan R; Tonks ID; Mould AW; Waring P; Muller HK; Kay GF; Hayward NK
    Oncogene; 2007 Jun; 26(27):4009-17. PubMed ID: 17173065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropilin-2 is a novel marker expressed in pancreatic islet cells and endocrine pancreatic tumours.
    Cohen T; Herzog Y; Brodzky A; Greenson JK; Eldar S; Gluzman-Poltorak Z; Neufeld G; Resnick MB
    J Pathol; 2002 Sep; 198(1):77-82. PubMed ID: 12210066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amylin-like immunoreactivity in the extra-islet peptide YY-producing and glucagon-immunoreactive cells in Japanese quail pancreas.
    Yanagida B; Yamamoto T; Suzuki H
    Anat Histol Embryol; 2024 Jul; 53(4):e13074. PubMed ID: 38864153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of amyloid deposition in various regions of the feline pancreas by different staining techniques.
    Lutz TA; Rand JS
    J Comp Pathol; 1997 Feb; 116(2):157-70. PubMed ID: 9131431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucagon-like-peptide-1 receptor expression in normal and diseased human thyroid and pancreas.
    Waser B; Blank A; Karamitopoulou E; Perren A; Reubi JC
    Mod Pathol; 2015 Mar; 28(3):391-402. PubMed ID: 25216224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Agouti signaling protein stimulates islet amyloid polypeptide (amylin) secretion in pancreatic beta-cells.
    Xue B; Zemel MB
    Exp Biol Med (Maywood); 2001 Jun; 226(6):565-9. PubMed ID: 11395927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of caveolin-1 and caveolin-2 in the human pituitary: an immunohistochemical study.
    Rotondo F; Horvath E; Kovacs K; Bell DC; Lloyd RV; Scheithauer BW
    Endocr Pathol; 2004; 15(4):345-50. PubMed ID: 15681859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of pancreatic glucagon-producing tumors and pituitary gland tumors in transgenic mice overexpressing MYCN in hGFAP-positive cells.
    Fielitz K; Althoff K; De Preter K; Nonnekens J; Ohli J; Elges S; Hartmann W; Klöppel G; Knösel T; Schulte M; Klein-Hitpass L; Beisser D; Reis H; Eyking A; Cario E; Schulte JH; Schramm A; Schüller U
    Oncotarget; 2016 Nov; 7(46):74415-74426. PubMed ID: 27769070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An unusual presentation of a benign pancreatic lesion containing amyloid.
    Kim D; Crook T; Ramzan Z
    BMJ Case Rep; 2017 Jul; 2017():. PubMed ID: 28739611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical assessment of Pax8 expression during pancreatic islet development and in human neuroendocrine tumors.
    Lorenzo PI; Jimenez Moreno CM; Delgado I; Cobo-Vuilleumier N; Meier R; Gomez-Izquierdo L; Berney T; Garcia-Carbonero R; Rojas A; Gauthier BR
    Histochem Cell Biol; 2011 Nov; 136(5):595-607. PubMed ID: 21932072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of Novel PET Imaging Probes for Detection of Amylin Aggregates in the Pancreas.
    Watanabe H; Kawano K; Shimizu Y; Iikuni S; Nakamoto Y; Togashi K; Ono M
    Mol Pharm; 2020 Apr; 17(4):1293-1299. PubMed ID: 32202808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amylin proprotein processing generates progressively more amyloidogenic peptides that initially sample the helical state.
    Yonemoto IT; Kroon GJ; Dyson HJ; Balch WE; Kelly JW
    Biochemistry; 2008 Sep; 47(37):9900-10. PubMed ID: 18710262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of (99m)Tc-Labeled Pyridyl Benzofuran Derivatives To Detect Pancreatic Amylin in Islet Amyloid Model Mice.
    Yoshimura M; Ono M; Watanabe H; Kimura H; Saji H
    Bioconjug Chem; 2016 Jun; 27(6):1532-9. PubMed ID: 27219875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amylin immunoreactivity in the rat trachea and characterization of the interaction of amylin and somatostatin on airway mucus secretion.
    Wagner U; Bredenbröker D; Barth PJ; Fehmann HC; von Wichert P
    Res Exp Med (Berl); 1995; 195(5):289-96. PubMed ID: 8578004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.